Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00312338 · ClinicalTrials.gov registry record · Phase 4
Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 137
- Enrollment target
NCT00312338 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 137 participants.
The verdict
NCT00312338, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 137 participants
- Enrollment target
Study Summary
Topical Treatment of Bacterial Conjunctivitis and its Effect on Microbial Flora
Interventions
- DRUG VIGAMOX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00312338
The ClinicalTrials.gov registry entry for NCT00312338 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VIGAMOX is the first listed.
NCT00312338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00312338 about?
NCT00312338 is a clinical study titled "Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora". Topical Treatment of Bacterial Conjunctivitis and its Effect on Microbial Flora
What is the current status of trial NCT00312338?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 137 participants. The study started on 2006-06. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00312338?
The interventions under investigation include: VIGAMOX (DRUG).
Who is sponsoring clinical trial NCT00312338?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.